[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$syre
$SYRE surges on social media buzz following Deutsche Bank's buy rating and a $XX price target. Investors are watching closely as engagements are up significantly, with the stock's public offering announcement driving further interest.
About $syre
Analysis of social media activity related to the stock ticker $SYRE.
Insights #
- $syre engagements is up XXXXXX% from the previous week.
- $syre posts created is up XXXXX% from the previous week.
Engagements: XXXXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
1 Week: XXXXXX +343%
1 Month: XXXXXX -XXXX%
6 Months: XXXXXXX -XX%
1 Year: XXXXXXX -XX%
1-Year High: XXXXXX on 2024-11-12
1-Year Low: X on 2025-09-06
| Social Network | X |
|---|---|
| Engagements | XXXXX |
Mentions: XX #
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
6 Months: XXX +188%
1 Year: XXX +201%
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2025-02-13
| Social Network | X |
|---|---|
| Mentions | XX |
Creators: XX #
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $syre in the last XX hours which is no change from in the previous XX hours
Daily Average: XX
6 Months: XXX +607%
1 Year: XXX +368%
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2025-02-13
The most influential creators that mention $syre in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @lifesciencerpt | X | XXXXX | X | XXX |
| @BiopharmIQ | X | XXXXXX | X | XXX |
| @Brad_E_Schulz | X | XXXXXX | X | XX |
| @Lycanbull | X | XXXXX | X | XX |
| @bioinvestor24 | X | XXXXX | X | XX |
Sentiment: XX% #
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Month: XX% -XX%
6 Months: XX% -XX%
1 Year: XX% -XX%
1-Year High: XXX% on 2024-10-17
1-Year Low: XX% on 2025-10-03
Most Supportive Themes
- Deutsche Bank Buy Rating: (45%) Deutsche Bank initiated coverage with a buy rating and a $XX price target, sparking positive sentiment.
- Positive Analyst Outlook: (25%) Analysts see potential for leadership in the biologics pipeline.
Most Critical Themes
- General Market Mentions: (15%) Mentions of $SYRE alongside other stocks, without specific positive or negative commentary.
- Comparison to Competitors: (15%) Comparisons to other companies and drugs, which may be seen as a risk.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXX | X% | XXXXX | XX% | X | X% |
| Total | XXX | X% | XXXXX | XX% | X | X% |
Top assets mentioned In the posts about $syre in the last XX hours
Eli Lilly and Company (LLY) Eli Lilly and Company (LLY) Klaydice (DICE) Riot Platforms, Inc. (RIOT) Deutsche Bank Aktiengesellschaft (DB) Critical Metals Corp. Ordinary Shares (CRML) Pfizer, Inc. (PFE) Prometheus Biosciences, Inc. Common Stock (RXDX) Cere Network (CERE) Johnson & Johnson (JNJ)
Top topics mentioned In the posts about $syre in the last XX hours
primary market, stocks, stocks healthcare, $275m, $atxs, $tmq, $nva, $rckt, $gnpx, $1850share, ipo, brad, eli lilly, $lly, $dice, $morf, stocks bitcoin treasuries, riot platforms, $db, stocks financial services, $omer, $ovid, $phvs, $prax, $rnaz, $crml, $nvts, $abat, $eric, $ncna, $vor, $wwr, $thm, $npwr, $pfe, $rxdx, cere network, coins defi, $65top, johnson johnson, hosting, $ptgx, $cytk, $murs, $orka, shah, $200m, $1850sh, bloomberg, $3162m, stocks consumer cyclical, stocks technology, $verx, $dks, $kd, $prgo, $prtc, $pwsc, $qttb, 6 months, investment, $lxrx, $vtak, $sgml, $apge, $kep, $gll, $janx, $tkno, $xbi, summary, $atyr, $mlys, $cdtx, monaco, $spy, without a
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Spyre Therapeutics just pulled a monster move closing their public offering and nailing the underwriters full option for a mind-blowing $316.2M. $SYRE is rewriting biotechs power playbook. You either get in early or get left behind 😏 #SpyreTherapeutics #SYRE #biotech #stocks #WallStreet #finance #investing #IPO #stockmarket #biotechstocks #trading #investors #pharma #healthcare #capitalmarkets #innovation #biotechnews #marketbuzz #fundraising"
X Link @Solix_Trade 2025-10-15T20:18Z 2097 followers, XX engagements
"Spyre Therapeutics Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares for Gross Proceeds of $XXXXX Million $SYRE"
X Link @lifesciencerpt 2025-10-15T20:18Z 5366 followers, XXX engagements
"100new $NVA $WWR $ATXS $THM $NPWR $RCKT $DRUG $SSII $FLNC $SYRE $STOK $IONR $NRGV $TTI $INDI $ENGN $POWI $ALNT $LWLG $LAC $NNDM $BBAI $SEI $REKR $TNGX $ASMB $SHLS $VSAT $ORLA $NAMS $LUNR $LPTH $SMR $MVST $GEVO"
X Link @MammaaiutoY 2025-10-15T12:42Z XXX followers, XXX engagements
"Stocks I watch up at least XX% on =1.5xAvgVol for the day (==IPO in last X yrs): $NVA: 19xAV; +110.3% (Materials)== $TMQ: 7.8xAV; +61.6% (Materials) $AREC: 6.3xAV; +36.7% (Fuel/Elec/Util:Coal) $SYRE: 6.1xAV; +11% (Bio/Pharm) $TTI: 5.5xAV; +13.5% (Oil&Gas) $DBRG: 5.1xAV; +15.7% (Tech Services:DataCenters) $ALM: 4.7xAV; +15.3% (Materials:Tungsten) $CRML: 4.2xAV; +28.7% (Materials:Lithium)== $ORLA: 4xAV; +14.3% (Materials:Gold)== $LAES: 4xAV; +24.8% (Semiconductors:Quantum)== $KOPN: 3.8xAV; +16.2% (Semiconductors) $NVTS: 3.6xAV; +26.1% (Semiconductors)== $INDI: 3.4xAV; +18.6% (Semiconductors)"
X Link @Brad_E_Schulz 2025-10-14T21:18Z 17.6K followers, XXX engagements